Hu, X., Huang, Y., Yuan, G., Zang, M., Wang, K., Li, Q., Liu, H., Zhu, P., Zhao, J., Chen, J. (2026). Donafenib and sintilimab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A phase II, biomarker exploratory study (DosinTACE).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.549